31.36

6.13% 1.81

After Hours: 31.34 -0.02 -0.06%

Assembly Biosciences Inc (ASMB)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Assembly Biosciences Inc stock is traded at $31.36, with a volume of 156.20K. It is up +6.13% in the last 24 hours and up +7.32% over the past month. Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.

Previous Close:

$29.55

Open:

$29.55

24h Volume:

156.20K

Relative Volume:

1.49

Market Cap:

$498.39M

Revenue:

$72.30M

Net Income/Loss:

$-6.12M

P/E Ratio:

-17.06

EPS:

-1.8384

Net Cash Flow:

$-41.16M

1W Performance:

+19.10%

1M Performance:

+7.32%

6M Performance:

+0.48%

1Y Performance:

+148.10%

1-Day Range:

$29.49

$31.61

1-Week Range:

$26.15

$31.61

52-Week Range:

$11.64

$39.70

Assembly Biosciences Inc Stock (ASMB) Company Profile

Name

Assembly Biosciences Inc

Sector

Healthcare (1111)

Industry

Biotechnology (621)

Phone

(833) 409-4583

Address

TWO TOWER PLACE, SOUTH SAN FRANCISCO

Employee

Twitter

Next Earnings Date

2026-05-14

Latest SEC Filings

ASMB's Discussions on Twitter

Compare ASMB vs VRTX, REGN, ARGX, ALNY, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ASMB Assembly Biosciences Inc	31.36	469.63M	72.30M	-6.12M	-41.16M	-1.8384
VRTX Vertex Pharmaceuticals Inc	427.65	107.87B	12.32B	4.34B	3.19B	16.86
REGN Regeneron Pharmaceuticals Inc	721.05	73.63B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	807.55	49.42B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	303.00	40.20B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	313.32	33.06B	5.36B	287.73M	924.18M	2.5229

Assembly Biosciences Inc Stock (ASMB) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-24-25	Initiated	Citizens JMP	Mkt Outperform
Aug-18-25	Resumed	H.C. Wainwright	Buy
Mar-25-25	Initiated	Guggenheim	Buy
Sep-20-24	Upgrade	Jefferies	Hold → Buy
Sep-13-21	Initiated	H.C. Wainwright	Neutral
Sep-02-21	Downgrade	William Blair	Outperform → Mkt Perform
Mar-23-21	Downgrade	SVB Leerink	Outperform → Mkt Perform
Nov-06-20	Downgrade	Jefferies	Buy → Hold
Oct-19-20	Initiated	Truist	Buy
Oct-16-19	Initiated	Mizuho	Buy
Nov-19-18	Initiated	Leerink Partners	Outperform
Oct-08-18	Upgrade	B. Riley FBR	Neutral → Buy
Aug-08-18	Initiated	Robert W. Baird	Outperform
Apr-13-18	Downgrade	Chardan Capital Markets	Buy → Neutral
Jan-05-18	Initiated	B. Riley FBR, Inc.	Neutral
Nov-08-17	Initiated	Jefferies	Buy
May-30-17	Initiated	Chardan Capital Markets	Buy

View All

Assembly Biosciences Inc Stock (ASMB) Latest News

07:02 AM

How Assembly Biosciences Inc. (ASMB) Affects Rotational Strategy Timing - Stock Traders Daily

07:02 AM

May 04, 2026

Assembly Biosciences Inc expected to post a loss of 57 cents a shareEarnings Preview - TradingView

May 04, 2026

ASMB Reiterated by HC Wainwright & Co. -- Price Target Maintained at $50 - GuruFocus

May 04, 2026

May 02, 2026

MSN Money - MSN

May 02, 2026

Apr 30, 2026

Assembly Biosciences (ASMB) Projected to Post Quarterly Earnings on Thursday - MarketBeat

Apr 30, 2026

Apr 29, 2026

Assembly Biosciences (ASMB) Q4 earnings and revenues top estimates - MSN

Apr 29, 2026

Apr 27, 2026

ASMB Forecast, Price Target & Analyst Ratings | ASSEMBLY BIOSCIENCES INC (NASDAQ:ASMB) - ChartMill

Apr 27, 2026

Apr 25, 2026